Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase
摘要:
Herein, we describe the structure-activity relationship (SAR) of N,N-disubstituted phenylalanine series of NS5B polymerase inhibitors of hepatitis C. The NS5B polymerase inhibitory activity of the most active compound exhibited an IC50 Of 2.7 muM. (C) 2003 Elsevier Ltd. All rights reserved.
Compounds and methods for the treatment or prevention of flavivirus infections
申请人:Shire BioChem Inc.
公开号:US20030229053A1
公开(公告)日:2003-12-11
the present invention provides novel compounds represented by formula I:
1
or pharmaceutically acceptable salts thereof useful for treating Flaviviridae viral infection.